Navigation Links
CU Denver study finds serious challenges to 'New Urbanist' communities
Date:6/10/2014

major thoroughfares Martin Luther King and Central Park Blvds, he said. Marshall found that the 35 mph speed limit on Martin Luther King Blvd. was exceeded 18 percent of the time while the 30 mph on Central Park was exceeded 22 percent of the time.

"If we have streets in a New Urbanist neighborhood where it's possible for drivers to go 50, 60 or 70 mph, then we've done something wrong," Marshall said. "The problem is not a lack of police enforcement; it's a lack of self-enforcing streets."

The study also found that Stapleton and Lowry, a similar development nearby, lagged behind older Denver neighborhoods in terms of walking, biking and public transit use. That may change in 2016, Marshall said, when a commuter line from the central business district to Stapleton is completed, but that is not quite enough.

Marshall said Stapleton, with over 14,000 residents, does many things right. There is a lot of connectivity for pedestrians and bikes, there are great sidewalks, the schools and restaurants are close, and the area looks inviting.

But he said the downsides are also real.

"Stapleton serves as a reminder that the transportation design ideals of New Urbanism can too easily be compromised by a conventional traffic engineering mindset," Marshall said. "The results are higher-than-desired vehicle speeds on every kind of street; higher driving mode shares, and less walking, biking and transit use than peer neighborhoods in the region."

The solution requires a return to the original ideals of Stapleton with narrow, connected streets, less off-street parking, and less dependency on automobiles, he said.

"If we don't better deal with this disconnect between New Urbanist ideals and conventional engineering solutions, then Stapleton will end up just like any other auto-oriented development," Marshall said.


'/>"/>

Contact: David Kelly
david.kelly@ucdenver.edu
303-503-7990
University of Colorado Denver
Source:Eurekalert

Page: 1 2

Related biology news :

1. PuraMed BioScience®, Inc., Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver, CO Region to Coincide with the NACDSs Marketplace 2012 Trade Convention
2. American Society for Microbiology to host 113th General Meeting in Denver
3. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
4. Law that regulates shark fishery is too liberal: UBC study
5. New study will help protect vulnerable birds from impacts of climate change
6. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
7. BYU study: Using a gun in bear encounters doesnt make you safer
8. 15-year study: When it comes to creating wetlands, Mother Nature is in charge
9. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
10. Crystal structure of archael chromatin clarified in new study
11. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Cellecta, Inc., ... gene function analysis and biomarker discovery, announced the ... Knockout Library targeting all human protein coding genes. ... "knock out" a gene,s function. Cellecta,s new Human ... throughput screening tool so that researchers can investigate ...
(Date:7/21/2015)... Sweden , July 21, 2015 Today, ... FPC1025. Already received as well as expected revenues in 2015 that ... in FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... selected FPC1 02 5 for Axon ...
(Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... can lead to cellular changes in the cervix that ... of these pre-stages gives an increased risk of preterm ... pre-stages of cervical cancer, it may therefore reduce the ... calculated the benefits of HPV-vaccination. Cervical cancer ...
... Alexandria, Va. The 2009 Wilmer Souder Award is ... of,Colorado, Aurora, USA. The International Association for Dental Research ... & Exhibition in Miami, Florida, USA, on April 1, ... of Craniofacial Biology at the University of Colorado School ...
... of The Proceedings of the National Academy of Sciences ... "alpha-synuclein dance" the switching back and forth of the ... the surface that it is binding to changes. Such ... like alpha-synuclein, which are known to be unfolded in isolation, ...
Cached Biology News:HPV vaccine may prevent preterm births 2Scripps research scientists 'watch' as individual alpha-synuclein proteins change shape 2Scripps research scientists 'watch' as individual alpha-synuclein proteins change shape 3
(Date:7/31/2015)... ... 31, 2015 , ... R-Biopharm is proud to announce the ... in foods, has been accepted by AOAC International as Official First Action method. ... Cereal-Based Products by R5 Competitive ELISA,” based on a specific monoclonal antibody to ...
(Date:7/30/2015)... Mass. , July 30, 2015   ... solutions for the interpretation and analysis of genomic ... Matthew Fischer has joined the company as ... Photo - http://photos.prnewswire.com/prnh/20150730/250931 ... capabilities to integrate, interpret, analyze and explore complex ...
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
(Date:7/30/2015)... July 30, 2015   Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... today reported financial results for the second quarter 2015. ... 2015, we remain on track to achieve our commercial ... Executive Officer of the Company. "Since our last quarterly ...
Breaking Biology Technology:RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9
... March 7, 2012 Karyopharm Therapeutics Inc., a leader ... nine presentations covering its Selective Inhibitors of Nuclear Export ... meeting on March 31 – April 4, 2012, in ... studying the use of Karyopharm,s novel SINE, along with ...
... Inc. (OTC/BB: PROT) announced today that it has ... to which the Company has agreed to sell shares ... aggregate purchase price of approximately $3.8 million (which are ... common stock) and Series A, Series B and Series ...
... NEW YORK, March 5, 2012  Organovo, Inc., (OTCQB: ... on using its breakthrough NovoGen 3D human tissue ... research and medical applications, today announced that their ... on-demand viewing. LINK:    www.retailinvestorconferences.com ...
Cached Biology Technology:Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting 2Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting 3Proteonomix Announces a Private Placement of $3.8 Million 2Proteonomix Announces a Private Placement of $3.8 Million 3Proteonomix Announces a Private Placement of $3.8 Million 4Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com 2
... different Cynomolgus monkey normal tissues are ... upon request. Customers can choose ... set, and pay 70% of the ... P Set products are for research ...
...
Immunogen: Recombinant full length protein, corresponding to amino acids 1-435 of Human AP2M1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
cysteine and glycine-rich protein 2,...
Biology Products: